Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field?
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference80 articles.
1. Proprotein convertases in health and disease;Artenstein;N Engl J Med,2011
2. Living the PCSK9 adventure: from the identification of a new gene in familial hypercholesterolemia towards a potential new class of anticholesterol drugs;Abifadel;Curr Atheroscler Rep,2014
3. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation;Seidah;Proc Natl Acad Sci U S A,2003
4. A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32;Varret;Am J Hum Genet,1999
5. Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred;Hunt;Arterioscler Thromb Vasc Biol,2000
Cited by 148 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. HDAC9 Inhibition as a Novel Treatment for Stroke;Stroke;2023-12
2. Serum and genetic markers related to rapid clinical progression of coronary artery disease;Revista Española de Cardiología (English Edition);2023-12
3. Marcadores genéticos y séricos relacionados con una rápida progresión clínica de la arteriosclerosis coronaria;Revista Española de Cardiología;2023-12
4. Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups;Bioorganic & Medicinal Chemistry Letters;2023-08
5. Trends in Short‐, Intermediate‐, and Long‐Term Mortality Following Hospitalization for Myocardial Infarction Among Medicare Beneficiaries, 2008 to 2018;Journal of the American Heart Association;2023-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3